
Sabiha Naim Qazi
Examiner (ID: 14019, Phone: (571)272-0622 , Office: P/1621 )
| Most Active Art Unit | 1616 |
| Art Unit(s) | 1621, 1611, 1627, 1202, 1616, 1612, 1629, 1628 |
| Total Applications | 2032 |
| Issued Applications | 930 |
| Pending Applications | 195 |
| Abandoned Applications | 909 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5959812
[patent_doc_number] => 20110184199
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-07-28
[patent_title] => 'Methods For Producing Paricalcitol'
[patent_app_type] => utility
[patent_app_number] => 13/055182
[patent_app_country] => US
[patent_app_date] => 2009-07-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 30117
[patent_no_of_claims] => 103
[patent_no_of_ind_claims] => 63
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0184/20110184199.pdf
[firstpage_image] =>[orig_patent_app_number] => 13055182
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/055182 | Methods for producing paricalcitol | Jul 21, 2009 | Issued |
Array
(
[id] => 6177544
[patent_doc_number] => 20110178052
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-07-21
[patent_title] => '9-ALPHA ESTRATRIENE DERIVATIVES AS ER-BETA SELECTIVE LIGANDS FOR THE PREVENTION AND TREATMENT OF INTESTINAL CANCER'
[patent_app_type] => utility
[patent_app_number] => 13/003360
[patent_app_country] => US
[patent_app_date] => 2009-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 6408
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0178/20110178052.pdf
[firstpage_image] =>[orig_patent_app_number] => 13003360
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/003360 | 9-ALPHA ESTRATRIENE DERIVATIVES AS ER-BETA SELECTIVE LIGANDS FOR THE PREVENTION AND TREATMENT OF INTESTINAL CANCER | Jul 8, 2009 | Abandoned |
Array
(
[id] => 5398232
[patent_doc_number] => 20090318295
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-24
[patent_title] => 'Solid herbicidal formulation of N-(phosphono-methyl)glycine and process for its preparation'
[patent_app_type] => utility
[patent_app_number] => 12/457557
[patent_app_country] => US
[patent_app_date] => 2009-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2251
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0318/20090318295.pdf
[firstpage_image] =>[orig_patent_app_number] => 12457557
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/457557 | Solid herbicidal formulation of N-(phosphono-methyl)glycine and process for its preparation | Jun 14, 2009 | Abandoned |
Array
(
[id] => 5986784
[patent_doc_number] => 20110098261
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-04-28
[patent_title] => 'TRITERPENOID-BASED COMPOUNDS USEFUL AS VIRUS INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 12/996331
[patent_app_country] => US
[patent_app_date] => 2009-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 9010
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0098/20110098261.pdf
[firstpage_image] =>[orig_patent_app_number] => 12996331
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/996331 | TRITERPENOID-BASED COMPOUNDS USEFUL AS VIRUS INHIBITORS | Jun 3, 2009 | Abandoned |
Array
(
[id] => 6257038
[patent_doc_number] => 20100029603
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-02-04
[patent_title] => '16ALPHA-METHYL OR ETHYL SUBSTITUTED ESTROGENS'
[patent_app_type] => utility
[patent_app_number] => 12/475096
[patent_app_country] => US
[patent_app_date] => 2009-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5390
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0029/20100029603.pdf
[firstpage_image] =>[orig_patent_app_number] => 12475096
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/475096 | 16ALPHA-METHYL OR ETHYL SUBSTITUTED ESTROGENS | May 28, 2009 | Abandoned |
Array
(
[id] => 6320605
[patent_doc_number] => 20100113400
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-05-06
[patent_title] => '9-Aminomethyl Substituted Minocycline Compounds'
[patent_app_type] => utility
[patent_app_number] => 12/473955
[patent_app_country] => US
[patent_app_date] => 2009-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12453
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0113/20100113400.pdf
[firstpage_image] =>[orig_patent_app_number] => 12473955
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/473955 | 9-Aminomethyl Substituted Minocycline Compounds | May 27, 2009 | Abandoned |
Array
(
[id] => 6121617
[patent_doc_number] => 20110077297
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-31
[patent_title] => 'COMPOSITIONS AND METHODS FOR TREATMENT OF INFLAMMATION AND HYPERKERATOTIC LESIONS'
[patent_app_type] => utility
[patent_app_number] => 12/995116
[patent_app_country] => US
[patent_app_date] => 2009-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 10764
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0077/20110077297.pdf
[firstpage_image] =>[orig_patent_app_number] => 12995116
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/995116 | COMPOSITIONS AND METHODS FOR TREATMENT OF INFLAMMATION AND HYPERKERATOTIC LESIONS | May 27, 2009 | Abandoned |
Array
(
[id] => 5316742
[patent_doc_number] => 20090281340
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-11-12
[patent_title] => '1ALPHA-HYDROXY-2-(3\'-HYDROXYPROPYLIDENE)-19-NOR-VITAMIN D COMPOUNDS AND METHODS OF MAKING AND TREATMENT THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/437892
[patent_app_country] => US
[patent_app_date] => 2009-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 11589
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0281/20090281340.pdf
[firstpage_image] =>[orig_patent_app_number] => 12437892
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/437892 | 1ALPHA-HYDROXY-2-(3'-HYDROXYPROPYLIDENE)-19-NOR-VITAMIN D COMPOUNDS AND METHODS OF MAKING AND TREATMENT THEREOF | May 7, 2009 | Abandoned |
Array
(
[id] => 6055697
[patent_doc_number] => 20110112057
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-05-12
[patent_title] => 'Sequential administration of 20,20,21,21,21-pentafluoro-17-hydroxy-11Beta-[4-(hydroxyacetyl)phenyl]-19-nor-17Alpha-pregna-4,9-dien-3-one and one or more progestogens for the treatment of gynaecological disorders'
[patent_app_type] => utility
[patent_app_number] => 12/992127
[patent_app_country] => US
[patent_app_date] => 2009-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5234
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0112/20110112057.pdf
[firstpage_image] =>[orig_patent_app_number] => 12992127
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/992127 | Sequential administration of 20,20,21,21,21-pentafluoro-17-hydroxy-11Beta-[4-(hydroxyacetyl)phenyl]-19-nor-17Alpha-pregna-4,9-dien-3-one and one or more progestogens for the treatment of gynaecological disorders | May 6, 2009 | Abandoned |
Array
(
[id] => 5486001
[patent_doc_number] => 20090275766
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-11-05
[patent_title] => 'PROCESS FOR THE PREPARATION OF TIGECYCLINE IN THE AMORPHOUS FORM'
[patent_app_type] => utility
[patent_app_number] => 12/435094
[patent_app_country] => US
[patent_app_date] => 2009-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1222
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0275/20090275766.pdf
[firstpage_image] =>[orig_patent_app_number] => 12435094
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/435094 | PROCESS FOR THE PREPARATION OF TIGECYCLINE IN THE AMORPHOUS FORM | May 3, 2009 | Abandoned |
Array
(
[id] => 6025946
[patent_doc_number] => 20110053900
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-03
[patent_title] => 'PROGESTERONE ANTAGONISTS SUCH AS CDB-4124 IN THE TREATMENT OF BREAST CANCER'
[patent_app_type] => utility
[patent_app_number] => 12/990210
[patent_app_country] => US
[patent_app_date] => 2009-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 16640
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0053/20110053900.pdf
[firstpage_image] =>[orig_patent_app_number] => 12990210
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/990210 | PROGESTERONE ANTAGONISTS SUCH AS CDB-4124 IN THE TREATMENT OF BREAST CANCER | Apr 26, 2009 | Abandoned |
Array
(
[id] => 5527848
[patent_doc_number] => 20090197925
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-06
[patent_title] => 'O-CYCLOPROPYL-CARBOXANILIDES AND THEIR USE'
[patent_app_type] => utility
[patent_app_number] => 12/420440
[patent_app_country] => US
[patent_app_date] => 2009-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9999
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0197/20090197925.pdf
[firstpage_image] =>[orig_patent_app_number] => 12420440
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/420440 | O-CYCLOPROPYL-CARBOXANILIDES AND THEIR USE | Apr 7, 2009 | Abandoned |
Array
(
[id] => 5373703
[patent_doc_number] => 20090311264
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-17
[patent_title] => 'Use of Disorazoles and Their Derivatives for the Treatment of Benign and Malignant Oncoses'
[patent_app_type] => utility
[patent_app_number] => 12/263981
[patent_app_country] => US
[patent_app_date] => 2009-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 3728
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0311/20090311264.pdf
[firstpage_image] =>[orig_patent_app_number] => 12263981
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/263981 | Use of Disorazoles and Their Derivatives for the Treatment of Benign and Malignant Oncoses | Apr 6, 2009 | Abandoned |
Array
(
[id] => 6033942
[patent_doc_number] => 20110082306
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-04-07
[patent_title] => 'BIRCH REDUCTION OF STEROID SUBSTRATES VIA ALKALI METAL - SILICA GEL MATERIALS'
[patent_app_type] => utility
[patent_app_number] => 12/933971
[patent_app_country] => US
[patent_app_date] => 2009-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5795
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0082/20110082306.pdf
[firstpage_image] =>[orig_patent_app_number] => 12933971
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/933971 | BIRCH REDUCTION OF STEROID SUBSTRATES VIA ALKALI METAL - SILICA GEL MATERIALS | Mar 23, 2009 | Abandoned |
Array
(
[id] => 6353939
[patent_doc_number] => 20100331539
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-30
[patent_title] => 'PROCESS FOR THE PREPARATION OF PREGNANE DERIVATIVES'
[patent_app_type] => utility
[patent_app_number] => 12/866577
[patent_app_country] => US
[patent_app_date] => 2009-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3760
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0331/20100331539.pdf
[firstpage_image] =>[orig_patent_app_number] => 12866577
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/866577 | PROCESS FOR THE PREPARATION OF PREGNANE DERIVATIVES | Mar 11, 2009 | Abandoned |
Array
(
[id] => 5534101
[patent_doc_number] => 20090233889
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-17
[patent_title] => 'STABILIZED 1,25-DIHYDROXYVITAMIN D2 AND METHOD OF MAKING SAME'
[patent_app_type] => utility
[patent_app_number] => 12/403271
[patent_app_country] => US
[patent_app_date] => 2009-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 3802
[patent_no_of_claims] => 50
[patent_no_of_ind_claims] => 31
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0233/20090233889.pdf
[firstpage_image] =>[orig_patent_app_number] => 12403271
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/403271 | STABILIZED 1,25-DIHYDROXYVITAMIN D2 AND METHOD OF MAKING SAME | Mar 11, 2009 | Abandoned |
Array
(
[id] => 5304286
[patent_doc_number] => 20090298938
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-03
[patent_title] => 'USE OF SEMI SYNTHETIC ANALOGUES OF BOSWELLIC ACIDS FOR ANTICANCER ACTIVITY'
[patent_app_type] => utility
[patent_app_number] => 12/401337
[patent_app_country] => US
[patent_app_date] => 2009-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 8353
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0298/20090298938.pdf
[firstpage_image] =>[orig_patent_app_number] => 12401337
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/401337 | USE OF SEMI SYNTHETIC ANALOGUES OF BOSWELLIC ACIDS FOR ANTICANCER ACTIVITY | Mar 9, 2009 | Abandoned |
Array
(
[id] => 5386300
[patent_doc_number] => 20090227545
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-10
[patent_title] => 'METHODS OF INCREASING EPIDERMAL SKIN THICKNESS BY TOPICAL ADMINISTRATION OF A 19-NOR CONTAINING VITAMIN D COMPOUND'
[patent_app_type] => utility
[patent_app_number] => 12/399070
[patent_app_country] => US
[patent_app_date] => 2009-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 7081
[patent_no_of_claims] => 58
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0227/20090227545.pdf
[firstpage_image] =>[orig_patent_app_number] => 12399070
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/399070 | Methods of increasing epidermal skin thickness by topical administration of a 19-nor containing vitamin D compound | Mar 5, 2009 | Issued |
Array
(
[id] => 6590107
[patent_doc_number] => 20100130455
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-05-27
[patent_title] => 'BISMETHYLENE-17A CARBOLACTONES AND RELATED USES'
[patent_app_type] => utility
[patent_app_number] => 12/397996
[patent_app_country] => US
[patent_app_date] => 2009-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 14455
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0130/20100130455.pdf
[firstpage_image] =>[orig_patent_app_number] => 12397996
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/397996 | Bismethylene-17A carbolactones and related uses | Mar 3, 2009 | Issued |
Array
(
[id] => 11343486
[patent_doc_number] => 09527881
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-12-27
[patent_title] => 'Steroid analogues for neuroprotection'
[patent_app_type] => utility
[patent_app_number] => 12/918036
[patent_app_country] => US
[patent_app_date] => 2009-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 47956
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12918036
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/918036 | Steroid analogues for neuroprotection | Feb 25, 2009 | Issued |